MedPath

Dynamic Stabilization Versus Fusion

Not Applicable
Completed
Conditions
Degeneration of Lumbar Intervertebral Disc
Interventions
Procedure: standard
Procedure: new
Registration Number
NCT01365754
Lead Sponsor
Technical University of Munich
Brief Summary

The purpose of this study is to compare posterior dynamic stabilization with fusion in the treatment of lumbar degenerative disease.

Detailed Description

Two strategies for treatment of degenerative lumbar instability are in frequent clinical use: fusion versus dynamic stabilization. Up to now it is not clear whether fusion (Gold-standard) or the non-fusion technique is superior. Nevertheless some data are available that dynamic stabilization as a less invasive technique can achieve similar or better results concerning patient satisfaction and re-OP rate compared with fusion as the standard therapy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
440
Inclusion Criteria
  • Age >18 years
  • Mono- or bisegmental symptomatic lumbar degenerative disease with or without stenosis
  • Indication for fusion with (i) spondylolisthesis of at least 5mm or segmental vertebral motion of at least 3mm or 10º on flexion/extension radiographs, (ii) predominant low back pain in combination with Modic changes
  • Failure of adequate conservative measures for more than 3 months
  • Correctly signed informed consent form
Exclusion Criteria
  • Olisthesis more than grade I, spondylolisthesis vera, spondylolysis without olisthesis or spinal deformity (i.e. scoliosis of more than 20°, sagittal imbalance)
  • Significant comorbidity impeding with surgical success (e.g. osteoporosis, rheumatoid arthritis, mental illness)
  • Previous fusion or stabilization surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AstandardA - Fusion
BnewB - Dynamic (new)
Primary Outcome Measures
NameTimeMethod
Difference in Oswestry disability index (ODI) between treatment groups at 2 years post intervention2 years after intervention
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Prof. Dr. med. Bernhard Meyer

🇩🇪

München, Germany

© Copyright 2025. All Rights Reserved by MedPath